JOHNSON INVESTMENT COUNSEL INC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 821197
Cincinnati, OH
Position in HALO
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,897,242
+$519,699 QoQ
Shares Held
37,016
+0.6% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#28
of 205 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 8%
Shared 0%
None 92%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JOHNSON INVESTMENT COUNSEL INC holds $10,648,095 across 9 Biotechnology names. HALO ranks #2 (27.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,360 | $3,655,932 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
This page
|
37,016 | $2,897,242 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
9,802 | $2,361,987 | |
| 4 | INCY |
Incyte Corp
|
4,681 | $530,638 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
8,212 | $451,167 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
4,000 | $326,040 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
468 | $291,816 | |
| 8 | AVIR |
Atea Pharmaceuticals, Inc.
|
25,590 | $118,993 |
All Filings in HALO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,897,242 | 37,016 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $2,377,543 | 36,787 | Shares | Sole | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||